| |
| |
|
| Insider
Information: |
Powell Fred M |
| Relationship: |
Executive Vice Preside... |
| City: |
Plymouth Meeting |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 415.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
BMP Sunstone Corp |
BJGP |
Chief Financial Officer |
2011-02-24 |
0 |
2008-05-22 |
0 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Executive Vice Preside... |
2022-05-24 |
0 |
2016-12-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2022-05-24 |
4 |
D |
$5.60 |
$5,125,512 |
D/D |
(915,270) |
0 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2022-03-03 |
4 |
D |
$3.80 |
$43,723 |
D/D |
(11,506) |
791,036 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
27,780 |
802,542 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2022-02-16 |
4 |
D |
$3.66 |
$42,075 |
D/D |
(11,496) |
774,762 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
24,606 |
786,258 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-06-13 |
4 |
D |
$4.45 |
$129,971 |
D/D |
(29,207) |
761,652 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-06-10 |
4 |
A |
$4.42 |
$380,001 |
D/D |
85,973 |
790,859 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-06-08 |
4 |
D |
$4.39 |
$52,878 |
D/D |
(12,045) |
704,886 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-03-01 |
4 |
D |
$4.50 |
$89,546 |
D/D |
(19,899) |
716,931 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,829 |
736,830 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
80,365 |
726,830 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2021-02-17 |
4 |
D |
$4.73 |
$169,471 |
D/D |
(35,829) |
691,001 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-11-12 |
4 |
B |
$2.85 |
$46,740 |
D/D |
16,400 |
646,465 |
2.74 |
% |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-06-13 |
4 |
D |
$2.78 |
$23,808 |
D/D |
(8,564) |
630,065 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-06-11 |
4 |
A |
$2.73 |
$360,000 |
D/D |
131,868 |
638,629 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-06-08 |
4 |
D |
$3.13 |
$27,178 |
D/D |
(8,683) |
506,761 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-06-07 |
4 |
D |
$3.12 |
$29,980 |
D/D |
(9,609) |
515,444 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-02-19 |
4 |
D |
$3.53 |
$83,982 |
D/D |
(23,791) |
525,053 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
63,234 |
548,844 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2019-06-13 |
4 |
A |
$2.92 |
$264,000 |
D/D |
90,411 |
485,610 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2019-06-08 |
4 |
D |
$2.81 |
$24,402 |
D/D |
(8,684) |
395,199 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2019-06-07 |
4 |
D |
$2.81 |
$27,001 |
D/D |
(9,609) |
403,883 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2018-06-08 |
4 |
A |
$2.70 |
$247,501 |
D/D |
91,667 |
413,492 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Executive Vice President & CFO |
• – – |
2018-06-07 |
4 |
D |
$2.70 |
$25,944 |
D/D |
(9,609) |
321,825 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Senior Vice President & CFO |
• – – |
2017-06-09 |
4 |
B |
$2.79 |
$363,272 |
D/D |
130,000 |
331,434 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
